Skip to content

Low-level Laser Therapy for the Treatment of Diabetic Foot Ulcer

Efficacy of Low-level Laser Therapy for the Treatment of Diabetic Foot Ulcer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03788642
Enrollment
20
Registered
2018-12-27
Start date
2019-01-15
Completion date
2021-10-31
Last updated
2021-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot Ulcer

Keywords

Diabetic Foot Ulcer, Low Level Laser Therapy

Brief summary

The study evaluates the efficacy of Low-level laser therapy on ulcer healing in patients with diabetic foot ulcer. Half the patients are randomized to receive Low-level laser therapy and a half to recieve the placebo (LED).

Detailed description

Low-level laser therapy(LLLT) has been reported to aid ulcer healing in patients with diabetic foot ulcer. However, patients need to come to hospital to receive LLLT performed by medical professional. The LLLT shoe has been developed for home using. Patients can wear LLLT shoe 30 min once daily instead of going hospital for LLT therapy. The aim of this study is to see whether LLLT shoe helps with healing compare with placebo (LED shoe).

Interventions

PROCEDUREControl LED shoe arm

Patients with DFU will wear LED shoe 30 minutes once daily

PROCEDURELaser Shoe arm

Patients with DFU will wear Laser shoe 30 minutes once daily

Sponsors

Mahidol University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

The randomised clinical trial with participants randomised1:1 to either * Control group : Patients will wear LED shoe (Placebo) 30 minutes once daily * Laser group : Patients will wear Laser shoe 30 minutes once daily

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients with chronic diabetic foot ulcer * Ankle brachial index ≥ 0.4 * Toe pressure brachial index ≥ 0.3 * Transcutaneous oxygen measurement (TCOM) ≥ 40 mmHg * Ulcer size less than 25 cm2

Exclusion criteria

* Infected ulcer * Fever * HbA1C \> 15 %

Design outcomes

Primary

MeasureTime frameDescription
Ulcer Healing Rate12 weeksHealing rate of control and laser group will be reported at 12 weeks

Secondary

MeasureTime frameDescription
Time to ulcer healingtime from date of randomisation to date of healing within the 12 month study periodFor the purposes of this study, ulcer healing is defined as complete re-epithelialization of all ulceration on the randomized leg in the absence of a scab (eschar) with no dressing required.
Clinical Success - Complicationsup to 12 monthsIncidence of complications related to the LLT shoe

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026